十人共览显微镜
Search documents
预算1.34亿元!北京大学近期大批仪器采购意向
仪器信息网· 2025-11-03 03:56
Core Insights - Peking University has announced procurement intentions for 26 items of laboratory equipment with a total budget of 134 million yuan, scheduled for procurement between September and December 2025 [1][2]. Equipment Procurement Overview - The procurement includes advanced instruments such as: - Small animal live imaging systems - High-throughput molecular interaction analysis instruments - Multifunctional photonic electron momentum microscopes - Biological microscopes, inverted microscopes, flow cytometers, and more [2][7]. - The total budget for the procurement is 134 million yuan, with specific allocations for various instruments [2][7]. Specific Equipment Descriptions - **Confocal Laser Scanning Microscope (CLSM)**: A high-resolution imaging device essential for modern biomedical research, utilizing laser scanning to achieve clear imaging and quantitative analysis [3]. - **Automated Microbial Sensitivity Analyzer**: A device for rapid detection of microbial species and antibiotic sensitivity, capable of processing multiple samples simultaneously [4]. - **Ten-Person Shared Microscope**: Designed for collaborative observation, allowing up to ten users to view the same specimen simultaneously, enhancing teamwork in research and education [6]. Detailed Procurement List - The procurement list includes: - 1 set of laser confocal microscope - 4 sets of biological microscopes - 2 sets of inverted microscopes - 1 set of flow cytometer - 1 set of ten-person shared microscope - 1 set of fluorescent quantitative PCR instrument - 1 set of automated microbial sensitivity analyzer - 20 sets of ultra-low temperature storage boxes, among others [8][9]. Budget Breakdown - The procurement intentions are categorized by budget, with significant allocations such as: - 139 million yuan for one batch - 109 million yuan for another batch - 97.39 million yuan for a third batch [7]. Future Implications - The planned procurement reflects Peking University's commitment to enhancing its research capabilities and infrastructure, particularly in the fields of biomedical research and molecular biology [1][2].